Skip to main content
. 2024 Mar 1;36:83–95. doi: 10.1016/j.bioactmat.2024.02.030

Scheme 1.

Scheme 1

Schematic illustration of (A) the fabrication procedures of the HA-based microneedle encapsulated with dual HSA-contained nanocomplexes (TPH/CH MN) and (B) the RA therapeutic mechanism through inducing RA FLS apoptosis and regulating inflammatory macrophages.